LAUSR

Emerging hormonal agents for the treatment of prostate cancer

Sign Up to like & get
recommendations!
2 Published in 2022 at "Expert Opinion on Emerging Drugs"

DOI: 10.1080/14728214.2022.2121390

Abstract: ABSTRACT Introduction Prostate cancer is the most common solid organ malignancy in men in the United States. Until recently, treatment options for men with metastatic disease were limited and patients faced poor outcomes with minimal… read more here.

Keywords: prostate cancer; hormonal agents; emerging hormonal; treatment ... See more keywords